Pulmonary Langerhans cell histiocytosis and other pulmonary histiocytic diseases: a review

Archives of Pathology and Laboratory Medicine

Volumn 132, Issue 7, 2008, Pages 1171-1181

  Allen, Timothy Craig ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CHOLESTEROL ESTER; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; INTERFERON; PIRFENIDONE; PREDNISONE; STEROID;

ANAMNESIS; CELL STRUCTURE; CHOLESTEROL ESTER STORAGE DISEASE; CLINICAL FEATURE; CYTOPLASM; DIABETIC XANTHOGRANULOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ERDHEIM CHESTER DISEASE; FABRY DISEASE; GAUCHER DISEASE; HISTIOCYTOSIS X; HUMAN; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LUNG FIBROSIS; LUNG HISTIOCYTOSIS; LUNG TRANSPLANTATION; NIEMANN PICK DISEASE; OCULAR ALBINISM; PHYSICAL EXAMINATION; PROGNOSIS; RADIODIAGNOSIS; REVIEW; ROSAI DORFMAN DISEASE; STEM CELL TRANSPLANTATION; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; XANTHOGRANULOMA;

DIAGNOSIS, DIFFERENTIAL; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LUNG DISEASES;

EID: 46849109718     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol. 1997;29:157-166.
2. Schmitz L, Favara BE. Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12:221-246.
3. Caminati A, Harari S. Smoking-related interstitial pneumonias and pulmonary Langerhans cell histiocytosis. Proc Am Thorac Soc. 2006;299-306.
4. Tazi A. Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J. 2006;27:1272-1285.
5. Vassallo R, Ryu JH, Colby TV, et al. Medical progress: pulmonary Langerhans' cell histiocytosis. N Engl J Med. 2000;346:1969-1978.
6. Yousem SA, Colby TV, Chen YY, et al. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol. 2001;25:630-636.
7. Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med. 2002;346:484-490.
8. Arico M, Girschikofsky M, Genereau T, et al. Langerhans cell histiocytosis in adults: report from the International Registry of the Histiocyte Society. Eur J Cancer. 2003;39:2341-2348.
9. Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am J Respir Crit Care Med. 2005;172:530-531.
10. Dacic S, Trusky C, Bakker A, et al. Genotypic analysis of pulmonary Langerhans' histiocytosis. Hum Pathol. 2003;34:1345-1349.
11. Willman CL, Busque L, Griffith BB, et al. Langerhans' cell histiocytosis (histiocytosis X): a clonal proliferative disease. N Engl J Med. 1994;331:154-160.
12. Yu RC, Chu C, Buluwela L, et al. Clonal proliferation of Langerhans' cells in Langerhans' cell histiocytosis. Lancet. 1994;343:767-768.
13. Willman CL. Detection of clonal histiocytes in Langerhans' cell histiocytosis: biology and clinical significance. Br J Cancer Suppl. 1994;23:S29-S33.
14. Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung: clinical aspects of primary pulmonary histiocytosis in the adult. Medicine (Baltimore). 1981;60:385-396.
15. Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans' cell histiocytosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol. 1993;17:971-986.
16. Schonfeld N, Frank W, Wenig S, et al. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration (Herrlisheim). 1993;60:38-44.
17. Miller LG, Goldstein G, Murphy M, Ginns LC. Reversible alterations in immunoregulatory T cells in smoking: analysis by monoclonal antibodies and flow cytometry. Chest. 1 1982;82:526-529.
18. Senior RM, Kuhn C III. The pathogenesis of emphysema. In: Fishman AP, ed. Pulmonary Diseases and Disorders. 2nd ed. New York, NY: McGraw-Hill; 1988:1209-1219.
19. Hoogsteden HC, van Hal PT, Wijkhuijs JM, Hop W, Verkaik AP, Hilvering C. Expression of the CD11/CD18 cell surface adhesion glycoprotein family on alveolar macrophages in smokers and nonsmokers. Chest. 1991;100:1567-1571.
20. Aguayo SM, King TE, Waldron JA, et al. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest. 1990;86:838-844.
21. Barth J, Kreipe H, Radzun HJ, et al. Increased expression of growth factor genes for macrophages and fibroblasts in bronchoalveolar lavage cells of a patient with pulmonary histiocytosis X. Thorax. 1991;46:835-838.
22. Tazi A, Moreau J, Bergeron A, et al. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol. 1999;163:3511-3515.
23. Gaensler AE, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic and physiological correlations in 502 patients. Ann Thorac Surg. 1980;30:411-426.
24. Agostini C, Albera C, Bariffi F, et al. First report of the Italian register for diffuse infiltrative lung disorders (RIPID). Monaldi Arch Chest Dis. 2001;56:364-368.
25. Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med. 2000;161:216-223.
26. LaCronique J, Roth C, Battesti JP, Basset F, Chretien J. Chest radiological features of pulmonary histiocytosis, X: a report based on 50 adult cases. Thorax. 1982;37:104-109.
27. Zeppa P, Cozzolino I, Rosso M, et al. Pulmonary Langerhans cell histiocytosis (histiocytosis, X) on bronchoalveolar lavage: a report of 2 cases. Acta Cytol. 2007;51:480-482.
28. Hoover KB, Rosenthal DI, Mankin H. Langerhans cell histiocytosis. Skeletal Radiol. 2007;36:95-104.
29. Birbeck MS, Breathnach AD, Everall JD. An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol. 1961;37:51-64.
30. Huhn D, Konig G, Weig J, Schneller W. Therapy in pulmonary histiocytosis X. Haematol Bluttransfus. 1981;27:231-237.
31. Von Essen S, West W, Sitorius M, Rennard SI. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest. 1990;98:765-767.
32. Mendez JL, Nadrous HF, Vassallo K, et al. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest. 2004;125:1028-1032.
33. Egan AJM, Boardman LA, Tazelaar HD, et al. Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol. 1999;23:17-26.
34. Rush WL, Andriko JAW, Galateau-Salle F, et al. Pulmonary pathology of Erdheim-Chester disease. Mod Pathol. 2000;13:747-754.
35. Allen TC, Chevez-Barrios P, Shetlar DJ, Cagle PT. Pulmonary and ophthalmic involvement with Erdheim-Chester disease: a case report and review of the literature. Arch Pathol Lab Med. 2004;128:1428-1431.
36. McClain KL, Natkunam Y, Swedlow SH. Atypical cellular disorders. Hematology Am Soc Hematol Educ Program. 2004:283-296.
37. Agarwal A, Pathak S, Gujral S. Sinus histiocytosis with massive lymphadenopathy-a review of seven cases. Indian J Pathol Microbiol. 2006;49:509-515.
38. Huang Q, Change KL, Weiss LM. Extranodal Rosai-Dorfman disease involving the bone marrow: a case report. Am J Surg Pathol. 2006;30:1189-1192.
39. Maric I, Pittaluga S, Dale J, Straus SE, Jaffe ES. Sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Mod Pathol. 2004;17:58A.
40. Bettinardi A, Brugnoni D, Qiros-Roldan E, et al. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood. 1997;89:902-909.
41. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ. 2003;10:124-133.
42. Sneller MC, Wang J, Dale JK, et al. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood. 1997;89:1341-1348.
43. Oner AY, Akpek S, Tali T. Rosai-Dorfman disease with epidural and spinal bone marrow involvement: magnetic resonance imaging and diffusion-weighted imaging features. Acta Radiol. 2007;48:331-334.
44. Ben Ghorbel I, Naffati H, Khanfir M, et al. Disseminated form of Rosai-Dorfman disease: a case report. Rev Med Interne. 2005;26:415-419.
45. Ohori NP, Jing Y, Landreneau RJ, Thaete FL. Rosai-Dorfman disease of the pleura: a rare extranodal presentation. Hum Pathol. 2003;1210-1211.
46. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;19-73.
47. Travis WD, Colby TV, Koss MN, et al. Non-Neoplastic Disorders of the Lower Respiratory Tract. Washington, DC: Armed Forces Institute of Pathology; 2002:144-147. Atlas of Nontumor Pathology; 1st series, fascicle 2.
48. Buchino JJ, Byrd RP, Kmetz DR. Disseminated sinus histiocytosis with massive lymphadenopathy: its pathologic aspects. Arch Pathol Lab Med. 1982;106:13-16.
49. Wright DH, Richards DB. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case with widespread nodal and extra nodal dissemination. Histopathology. 1981;5:697-709.
50. Rao NR, Chang C, Uysal N, et al. Fulminate multisystem non-Langerhans cell histiocytic proliferation with hemophagocytosis: a variant form of Erdheim Chester disease. Arch Pathol Lab Med. 2005;129:e39-e43.
51. Kong PM, Pinheiro L, Kaw G, Sittampalam K, Teo CHY. Erdheim-Chester disease: a rare cause of interstitial lung disease. Singapore Med J. 2007;48:e57-e59.
52. Saboerali MD, Koolen MGJ, Noorduyn LA, van Delden OM, Bogaard HJ. Pleural thickening in a construction worker: it is not always mesothelioma. Neth J Med. 2006;64:88-90.
53. Chung JH, Park MS, Shin DH, et al. Pulmonary involvement with Erdheim-Chester disease. Respirology. 2005;10:389-392.
54. Shaburek RD, Brewer HB, Gochuico BR. Erdheim-Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci. 2001;321:66-76.
55. Devouassoux G, Laintenjoul S, Chatelain P, et al. Erdheim-Chester disease: a primary macrophage disorder. Am J Respir Crit Care Med. 1998;157:650-653.
56. Wittenberg KH, Swensen SJ, Myers JL, et al. Pulmonary involvement with Erdheim-Chester disease: radiographic and CT findings. Am J Roentgenol. 2000;174:1271-3331.
57. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine. 1996;75:157-169.
58. Amir G, Ron N. Pulmonary pathology in Gaucher's disease. Hum Pathol. 1999;30:666-670.
59. Guggenbuhl P, Grosbois B, Chales G. Gaucher disease. Joint Bone Spine. 2008;75:116-124.
60. Mignot C, Doummar D, Maire I, et al. Type 2 Gaucher disease: 15 new cases and review of the literature. Brain Dev. 2006;28:39-48.
61. Miller A, Brown LK, Pastores GM, Desnick RJ. Pulmonary involvement in type 1 Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease. Clin Genet. 2003;63:368-376.
62. Rao AR, Parakininkas D, Hintermeyer M, Segura AD, Rice TB. Bilateral lung transplant in Gauchers type-1 disease. Pediatr Transplant. 2005;9:239-243.
63. Dinwiddle R, Sonnappa S. Systemic diseases and the lung. Paediat Resp Rev. 2005;6:181-189.
64. Fisher MR, Sider L. Diffuse reticulonodular infiltration associated with splenomegaly. Chest. 1983;84:609-610.
65. Schneider EL, Epstein CJ, Kaback MJ, et al. Severe pulmonary involvement in Gaucher's disease: report of three cases and review of the literature. Am J Med. 1977;63:475-480.
66. Wolson AA. Pulmonary findings in Gaucher's disease. Am J Roentgenol. 1975;123:712-715.
67. Roberts WC, Fredrickson DS. Gaucher's disease of the lung causing severe pulmonary hypertension with associated acute pericarditis. Circulation. 1967;35:783-789.
68. Lee RE, Yousem SA. The frequency and type of lung involvement in patients with Gaucher's disease. Lab Invest. 1988;58:54A.
69. Beutler E. Gaucher disease. Curr Opin Hematol. 1997;4:19-23.
70. Goitein O, Elstein D, Abrahamov A, et al. Lung involvement and enzyme replacement therapy in Gaucher's disease. Q J Med. 2001;94:407-415.
71. Griffiths GM. Gaucher disease: forging a new path to the lysosome. Cell. 2007;131:67-649.
72. Kelly MM, Leigh R, McKenzie R, et al. Induced sputum examination: diagnosis of pulmonary involvement in Fabry's disease. Thorax. 2000;55:720-721.
73. Eng CM, Germain DP, Banikazemi M, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med. 2006;8:539-548.
74. Mohrenschlager M, Pontz BF, Lanzi I, et al. Fabry disease: case report with emphasis on enzyme replacement therapy and possible future therapeutic options. J Dtsch Dermatol Ges. 2007;5:594-597.
75. Kim W, Pyeritz RE, Bernhardt BA, Casey M, Litt HI. Pulmonary manifestations of Fabry disease and positive response to enzyme replacement therapy. Am J Med Genet Part A. 2007;143A:377-381.
76. Brown LR, Miller A, Bhuptani A, et al. Pulmonary involvement with Fabry disease. Am J Respir Crit Care Med. 1997;155:1004-1010.
77. Peters FP, Sommer A, Vermeulen A, et al. Fabry's disease: a multidisciplinary disorder. Postgrad Med J. 1997;73:710-712.
78. Rosenberg DM, Ferrans VJ, Fulmer JD, et al. Chronic airflow obstruction in Fabry's disease. Am J Med. 1980;68:898-905.
79. Nicholson AG, Florio R, Hansell DM, et al. Pulmonary involvement by Niemann-Pick disease: a report of six cases. Histopathology. 2006;596-603.
80. Guillemot N, Troadec C, de Villemeur TB, Clement A, Fauroux B. Lung disease in Niemann-Pick disease. Pediatr Pulmonol. 2007;42:1207-1214.
81. Mendelson DS, Wasserstein MP, Desnick RJ, et al. Type B Niemann-Pick disease: findings at chest radiography, thin-section CT, and pulmonary function testing. Radiology. 2006;238:339-345.
82. Uyan ZS, Karadag B, Ersu R, et al. Early pulmonary involvement in Niemann-Pick type B disease: lung lavage is not useful. Pediatr Pulmonol. 2005;40:169-172.
83. Palmeri S, Tarugi P, Sicurelli F, et al. Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage. Neurol Sci. 2005;26:171-173.
84. Crocker AC, Farber S. Niemann-Pick disease: a review of eighteen patients. Medicine (Baltimore). 1958;37:1-95.
85. Minai OA, Sullivan EJ, Stoller JK. Pulmonary involvement in Niemann-Pick disease: case report and literature review. Resp Med. 2000;94:1241-1251.
86. Skikne MI, Prinsloo I, Webster I. Electron microscopy of lung in Niemann-Pick disease. J Pathol. 1972;106:119-122.
87. Niggemann B, Rebien W, Rahn W, et al. Asymptomatic pulmonary involvement in 2 children with Niemann-Pick disease type B. Respiration. 1994;61:55-57.
88. Long RG, Lake BD, Petetit JE, et al. Adult Niemann-Pick disease: its relationship to the syndrome of the sea-blue histiocyte. Am J Med. 1977;62:627-635.
89. Nicholson AC, Wells AU, Hooper J, et al. Successful treatment of endogenous lipoid pneumonia due to Niemann-pick Type B disease with whole-lung lavage. Am J Respir Crit Care Med. 2002;165:128-131.
90. Vellodi A, Hobbs JR, O'Donnell NM, et al. Treatment of Niemann-Pick disease type B by allogenic bone marrow transplantation. Br Med J (Clin Res Ed). 1987;295:1375-1376.
91. Terry RD, Sperry WM, Brodoff B. Adult lipidosis resembling Niemann-Pick's disease. Am J Pathol. 1954;30:263-285.
92. Verger P, Bentegeat J, Kermarec J, Serville F. Niemann-Pick disease in a 4-year old child without nervous manifestations: considerable significance of pulmonary respiratory signs. Arch Fr Pediatr. 1965;22:1109-1110.
93. Pierson DM, Ionescu D, Qing G, et al. Pulmonary fibrosis in Hermansky-Pudlak syndrome. Respiration. 2006;73:3882-395.
94. Wei ML. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle dysfunction. Pigment Cell Res. 2006;19:19-42.
95. Lederer DL, Kaut SM, Sonett JR, et al. Successful bilateral lung transplantation for pulmonary fibrosis associated with Hermansky-Pudlak syndrome. J Heart Lung Transplant. 2005;24:1697-1699.
96. Brantly M, Villia NA, Shotelersuk V, et al. Pulmonary function and high resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest. 2000;117:129-136.
97. Bachli EB, Brack T, Eppler E, et al. Hermansky-Pudlak syndrome type 4 in a patient from Sri Lanka with pulmonary fibrosis. Am J Met Genet. 2004;127A:201-207.
98. Gahl WA, Brantly M, Troendle J, et al. Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. Mol Genet Metab. 2002;76:234-242.
99. Reinilä A. Perivascular xanthogranulomatosis in the lungs of diabetic patients. Arch Pathol Lab Med. 1976;100:542-543.
100. Muntoni S, Wiebusch H, Jansen-Rust M, et al. Prevalence of cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol. 2007;27:1866-1868.
101. Seedorf U, Wiebusch H, Muntoni S, et al. A novel variant of lysosomal acid lipase (Leu336 → Pro) associated with acid lipase deficiency and cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol. 1995;15:773-778.
102. Muntoni S, Wiebusch H, Funke H, et al. Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesteryl ester storage disease (CESD). Hum Genet. 1995;95:491-494.
103. Pagani G, Garcia R, Pariyarath R, et al. Expression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease. Hum Mol Genet. 1996;5:1611-1617.
104. Klima H, Ullrich K, Aslanidis C, et al. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease. J Clin Invest. 1993;92:2713-2718.
105. Gasche C, Aslanidis C, Kain R, et al. A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin. J Hepatol. 1997;27:744-750.
106. Redonnnet-Vernhet I, Chatelut M, Basile JP, Salvayre R, Levade T. A novel lysosomal acid lipase gene mutation in a patient with cholesteryl ester storage disease. Hum Mutat. 1998;11:335-336.
107. Ameis D, Brockmann G, Knoblich R, et al. A 5′ splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage disease. J Lipid Res. 1995;36:241-250.
108. Elleder M, Chlumska A, Hyanek J, et al. Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer. J Hepathol. 2000;32:528-534.
109. Michels VV, Driscoll DJ, Ferry GD, Duff DF, Beaudet AL. Pulmonary vascular obstruction associated with cholesteryl ester storage disease. J Pediatr. 1979;94:621-623.
110. Cagle PT, Ferry GD, Beaudet AL, et al. Clinicopathologic conference: pulmonary hypertension in an 18-year old girl with cholesteryl ester storage disease (CESD). Am J Med Genet. 1986;24:711-722.